General
CSL injects $2.3b into US for valuable blood plasma
Australia’s largest biotech company plans to expand its US presence with a $US1.5 billion ($A2.3 billion) investment that will allow it to manufacture more therapies derived from blood…
Continue Reading
-
Business24 hours agoDown 56%! Why now is a strong entry point for WiseTech shares
-
Noosa News21 hours agoMan charged after ‘beautiful and gentle’ Olivia, 17, killed in alleged Margate hit-and-run a month before birthday
-
Business23 hours ago3 fantastic ASX ETFs to buy after the market selloff
-
Noosa News22 hours agoBusiness owner reveals torment of tax office’s seven-year pursuit